A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
formats

St. Jude Medical Announces Q4 2013 Results: CRM Up 4%, Neuromodulation Up 2%

St Jude Medical announced that its Cardiac Rhythm Management sales increased 5 percent on a constant-currency basis over the fourth quarter of 2012.  Neuromodulation sales for the same period increased by 2%.  According to the press release: Cardiac Rhythm Management Total CRM sales, which include implantable cardioverter defibrillator (ICD) and pacemaker products, were $705 million for

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude Medical Announces Q4 2013 Results: CRM Up 4%, Neuromodulation Up 2%  comments 
formats

Boston Scientific Announces Q4 2013 Results: CRM Up 3%

Boston Scientific announced that it has continued to improve performance in the company’s Cardiac Rhythm Management business, achieving revenue growth of 3 percent versus the prior year period on a constant currency basis from $457M to $468M.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific Announces Q4 2013 Results: CRM Up 3%  comments 
formats

Reveal LINQ: Medtronic’s New Miniaturized Insertable Cardiac Monitoring System

Medtronic’s new Reveal LINQ Insertable Cardiac Monitor is a tiny implantable device that weighs less than three grams and is far less invasive than any previous loop recorder.  The figure above shows its diminutive size compared to the Reveal XT device – it is a full 87% smaller!  The Reveal LINQ is a leadless device that

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Reveal LINQ: Medtronic’s New Miniaturized Insertable Cardiac Monitoring System  comments